Top Markets
#1 Songbird Songbird +9.45%
#2 Prom Prom +4.62%
#3 pipedog pipedog +4.04%
#4 TENDIES TENDIES +3.18%
#5 BORA BORA +3.18%
#6 Bitway Bitway +2.76%
#7 PulseX PulseX +2.66%
#8 Wrapped Pulse Wrapped Pulse +2.65%
#9 The Grays Currency The Grays Currency +2.46%
#10 o1.exchange o1.exchange +2.37%
Coin of the day
Songbird Songbird
Settings
Language
ENGLISH
Currency
USD
Theme
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Rank in Stocks #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Share Price
$19.81
Last synced: 2026-08-28
Market Cap
$891.32M
Change (1 day)
1.39%
Change (1 year)
5.16%
Country
US
Trade Beta Bionics, Inc. (BBNX)

Category

Healthcare
Revenue for Beta Bionics, Inc. (BBNX)
Revenue in Aug 2026 TTM: 0
According to Beta Bionics, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Beta Bionics, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE